is president and managing partner of BioPlan Associates.
The enthusiasm for India and China may be diminishing, writes Eric Langer.
Preliminary results from BioPlan Associates' 9th Annual Report and Survey of Biomanufacturing suggest there's a good reason to be optimistic about 2012.
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva